Form 4 for MED MEDIFAST INC
Accepted 2026-05-28 19:34:17 ET · period of report 2026-05-26 · accession 0001628280-26-038983 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-28 19:34 | 2026-05-26 | MED | Rose Jeffrey Matthew | Dir | A - Grant | $0.00 | +18.4K | 18.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-26 | A | A | 11,680 | $0.00 | 11,680 | D | — | — | (F1) These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on May 26, 2027. |
| 2 | Common | Common Stock | 2026-05-26 | A | A | 6,739 | $0.00 | 18,419 | D | — | — | (F2) The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer. |